Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts

Alfons A. den Broeder*, Noortje van Herwaarden, Bart J. F. van den Bemt

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)266-275
Number of pages10
JournalCurrent Opinion in Rheumatology
Volume30
Issue number3
DOIs
Publication statusPublished - May 2018

Keywords

  • biologicals
  • review
  • rheumatoid arthritis
  • therapeutic drug monitoring
  • SUCCESSFUL DOSE REDUCTION
  • ANTI-ADALIMUMAB ANTIBODIES
  • ANKYLOSING-SPONDYLITIS
  • CLINICAL UTILITY
  • DISCONTINUATION
  • INFLIXIMAB
  • ETANERCEPT
  • PREDICTION

Cite this